Systemic therapy for metastatic extramammary Paget's disease

Area of Science:

• Oncology
• Dermatology
• Medical Research

Background:

• Extramammary Paget's disease is a rare skin cancer.
• Metastatic cases have poor prognoses, requiring better treatments.
• No standard treatment consensus exists due to its rarity.

Purpose of the Study:

• To review current treatment modalities for metastatic extramammary Paget's disease.
• To explore emerging and novel therapeutic approaches.
• To identify needs for future clinical research.

Main Methods:

• Literature review of current treatment options.
• Summary of chemotherapy, hormonal therapy, and targeted therapy.
• Inclusion of immune checkpoint inhibitors and novel therapies.

Main Results:

• Current therapies show variable disease control and survival rates.
• Chemotherapy, targeted therapy, and immunotherapy are key treatment areas.
• Emerging therapies show potential but require further investigation.

Conclusions:

• Effective therapeutic strategies are needed to improve outcomes for metastatic extramammary Paget's disease.
• Further large-scale clinical studies are essential.
• Well-designed therapeutic trials are required to establish optimal treatment regimens.